Ivan S. Pires

978 total citations · 2 hit papers
32 papers, 591 citations indexed

About

Ivan S. Pires is a scholar working on Cell Biology, Molecular Biology and Physiology. According to data from OpenAlex, Ivan S. Pires has authored 32 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cell Biology, 12 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Ivan S. Pires's work include Hemoglobin structure and function (16 papers), Erythrocyte Function and Pathophysiology (8 papers) and Neonatal Health and Biochemistry (8 papers). Ivan S. Pires is often cited by papers focused on Hemoglobin structure and function (16 papers), Erythrocyte Function and Pathophysiology (8 papers) and Neonatal Health and Biochemistry (8 papers). Ivan S. Pires collaborates with scholars based in United States and Germany. Ivan S. Pires's co-authors include Darrell J. Irvine, Andre F. Palmer, Paula T. Hammond, Donald A. Belcher, Paul C. Blainey, Bingxu Liu, Rebecca J. Carlson, Marc A. Schwartz, Matteo Gentili and Nir Hacohen and has published in prestigious journals such as Science, Cell and Advanced Materials.

In The Last Decade

Ivan S. Pires

29 papers receiving 586 citations

Hit Papers

Vaccine-boosted CAR T cro... 2023 2026 2024 2023 2023 40 80 120

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ivan S. Pires 239 229 142 132 94 32 591
Charles C. Pak 185 0.8× 322 1.4× 63 0.4× 47 0.4× 50 0.5× 15 636
Urszula Cytlak 431 1.8× 198 0.9× 186 1.3× 27 0.2× 52 0.6× 15 826
Bai‐Liang He 131 0.5× 643 2.8× 56 0.4× 73 0.6× 98 1.0× 21 849
Ling Qiu 55 0.2× 486 2.1× 93 0.7× 72 0.5× 40 0.4× 27 706
Thierry Marysael 360 1.5× 207 0.9× 220 1.5× 106 0.8× 226 2.4× 5 719
M. Fairuz B. Jamaluddin 116 0.5× 314 1.4× 73 0.5× 34 0.3× 38 0.4× 23 645
Algirdas Grevys 181 0.8× 412 1.8× 50 0.4× 26 0.2× 73 0.8× 16 688
Jeremiah C. Davis 648 2.7× 121 0.5× 88 0.6× 37 0.3× 34 0.4× 6 999
Salim Abdisalaam 113 0.5× 341 1.5× 144 1.0× 48 0.4× 27 0.3× 13 527
Miguel de Jesus 104 0.4× 75 0.3× 96 0.7× 92 0.7× 54 0.6× 8 308

Countries citing papers authored by Ivan S. Pires

Since Specialization
Citations

This map shows the geographic impact of Ivan S. Pires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan S. Pires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan S. Pires more than expected).

Fields of papers citing papers by Ivan S. Pires

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan S. Pires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan S. Pires. The network helps show where Ivan S. Pires may publish in the future.

Co-authorship network of co-authors of Ivan S. Pires

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan S. Pires. A scholar is included among the top collaborators of Ivan S. Pires based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan S. Pires. Ivan S. Pires is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pires, Ivan S., et al.. (2025). High‐Throughput Microfluidic‐Mediated Assembly of Layer‐By‐Layer Nanoparticles. Advanced Functional Materials. 35(34). 2 indexed citations
2.
Pires, Ivan S., Gil Covarrubias, Coralie M. Backlund, et al.. (2025). IL-12-releasing nanoparticles for effective immunotherapy of metastatic ovarian cancer. Nature Materials. 25(2). 322–334.
3.
Buckley, Maureen, Mariluz Araínga, Laura Maiorino, et al.. (2025). Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates. Molecular Therapy. 33(3). 1105–1117. 12 indexed citations
4.
Muñoz, Carlos, Ivan S. Pires, Thekla Cordes, et al.. (2025). Resuscitation from Hemorrhagic Shock with a Novel Protein Cocktail Restores Microvascular Perfusion and Protects Vital Organs. Shock. 65(2). 294–308. 1 indexed citations
5.
Pires, Ivan S., Mariane B. Melo, Dong Soo Yun, et al.. (2025). Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoParticles (SMNP). Journal of Pharmaceutical Sciences. 114(9). 103913–103913.
6.
Pires, Ivan S., et al.. (2024). Surfactant-Mediated Assembly of Precision-Size Liposomes. Chemistry of Materials. 36(15). 7263–7273. 6 indexed citations
7.
Pires, Ivan S., et al.. (2024). Charge‐Stabilized Nanodiscs as a New Class of Lipid Nanoparticles. Advanced Materials. 36(52). e2408307–e2408307. 3 indexed citations
8.
Muñoz, Carlos, et al.. (2024). Mitigating hemoglobin‐induced nephropathy: ApoHb‐hp protection of podocytes. Physiological Reports. 12(22). e70132–e70132. 2 indexed citations
9.
Muñoz, Carlos, et al.. (2024). Toxic side-effects of diaspirin cross-linked human hemoglobin are attenuated by the apohemoglobin-haptoglobin complex. Biomedicine & Pharmacotherapy. 174. 116569–116569. 1 indexed citations
10.
Muñoz, Carlos, et al.. (2024). Coadministration of PEGylated apohemoglobin and haptoglobin can limit vascular dysfunction in the microcirculation and prevent acute inflammation. Journal of Applied Physiology. 137(4). 934–944. 1 indexed citations
11.
He, Yanpu, Celestine Hong, Gil Covarrubias, et al.. (2023). STING Protein‐Based In Situ Vaccine Synergizes CD4+ T, CD8+ T, and NK Cells for Tumor Eradication. Advanced Healthcare Materials. 12(24). e2300688–e2300688. 10 indexed citations
12.
Ma, Leyuan, Duncan M. Morgan, Laura Maiorino, et al.. (2023). Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity. Cell. 186(15). 3148–3165.e20. 128 indexed citations breakdown →
13.
Pires, Ivan S., Kaiyuan Ni, Mariane B. Melo, et al.. (2023). Controlled lipid self-assembly for scalable manufacturing of next-generation immune stimulating complexes. Chemical Engineering Journal. 464. 142664–142664. 9 indexed citations
14.
Smith, Sean G., Ivan S. Pires, Sonia Iyer, et al.. (2022). Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors. Bioengineering & Translational Medicine. 8(2). e10453–e10453. 25 indexed citations
15.
Moharil, Pearl, Natalie Boehnke, Richard Panayiotou, et al.. (2022). Synergistic combination therapy delivered via layer‐by‐layer nanoparticles induces solid tumor regression of ovarian cancer. Bioengineering & Translational Medicine. 8(2). e10429–e10429. 11 indexed citations
16.
Muñoz, Carlos, et al.. (2022). Apohemoglobin-haptoglobin complex alleviates iron toxicity in mice with β-thalassemia via scavenging of cell-free hemoglobin and heme. Biomedicine & Pharmacotherapy. 156. 113911–113911. 5 indexed citations
17.
Pires, Ivan S., et al.. (2021). Purification and analysis of a protein cocktail capable of scavenging cell‐free hemoglobin, heme, and iron. Transfusion. 61(6). 1894–1907. 6 indexed citations
18.
Pires, Ivan S., et al.. (2020). Poly(ethylene glycol) Surface-Conjugated Apohemoglobin as a Synthetic Heme Scavenger. Biomacromolecules. 21(6). 2155–2164. 11 indexed citations
19.
Pires, Ivan S. & Andre F. Palmer. (2020). Tangential flow filtration of haptoglobin. Biotechnology Progress. 36(5). 14 indexed citations
20.
Pires, Ivan S., et al.. (2020). Enhanced Photodynamic Therapy Using the Apohemoglobin-Haptoglobin Complex as a Carrier of Aluminum Phthalocyanine. ACS Applied Bio Materials. 3(7). 4495–4506. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026